These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 22994753

  • 1. MicroRNA expression profile analysis reveals diagnostic biomarker for human prostate cancer.
    Liu DF, Wu JT, Wang JM, Liu QZ, Gao ZL, Liu YX.
    Asian Pac J Cancer Prev; 2012; 13(7):3313-7. PubMed ID: 22994753
    [Abstract] [Full Text] [Related]

  • 2. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z, Yawei W, Lianna L, Haifeng L, Hui Z.
    Med Sci Monit; 2015 Dec 02; 21():3748-59. PubMed ID: 26628405
    [Abstract] [Full Text] [Related]

  • 3. Analysis of microRNA expression profile identifies novel biomarkers for non-small cell lung cancer.
    Xu C, Zheng Y, Lian D, Ye S, Yang J, Zeng Z.
    Tumori; 2015 Dec 02; 101(1):104-10. PubMed ID: 25702651
    [Abstract] [Full Text] [Related]

  • 4. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
    Song CJ, Chen H, Chen LZ, Ru GM, Guo JJ, Ding QN.
    J Cell Biochem; 2018 Mar 02; 119(3):2763-2786. PubMed ID: 29095529
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K.
    Int J Cancer; 2010 Mar 01; 126(5):1166-76. PubMed ID: 19676045
    [Abstract] [Full Text] [Related]

  • 6. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L, Filella X.
    Pathol Oncol Res; 2019 Oct 01; 25(4):1445-1456. PubMed ID: 30367364
    [Abstract] [Full Text] [Related]

  • 7. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C, Chen H, Wang T, Zhang W, Ru G, Lang J.
    Prostate; 2015 Apr 01; 75(5):500-16. PubMed ID: 25597612
    [Abstract] [Full Text] [Related]

  • 8. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
    Nguyen HC, Xie W, Yang M, Hsieh CL, Drouin S, Lee GS, Kantoff PW.
    Prostate; 2013 Mar 01; 73(4):346-54. PubMed ID: 22887127
    [Abstract] [Full Text] [Related]

  • 9. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
    Sharma N, Baruah MM.
    Clin Transl Oncol; 2019 Feb 01; 21(2):126-144. PubMed ID: 29951892
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.
    Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B.
    Int J Cancer; 2012 Feb 01; 130(3):611-21. PubMed ID: 21400514
    [Abstract] [Full Text] [Related]

  • 11. Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.
    He HC, Han ZD, Dai QS, Ling XH, Fu X, Lin ZY, Deng YH, Qin GQ, Cai C, Chen JH, Jiang FN, Liu X, Zhong WD.
    BMC Genomics; 2013 Nov 05; 14():757. PubMed ID: 24191917
    [Abstract] [Full Text] [Related]

  • 12. Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.
    Gu Y, Lei D, Qin X, Chen P, Zou YM, Hu Y.
    PLoS One; 2015 Nov 05; 10(10):e0140862. PubMed ID: 26484677
    [Abstract] [Full Text] [Related]

  • 13. Screening biomarkers of prostate cancer by integrating microRNA and mRNA microarrays.
    Feng J, Huang C, Diao X, Fan M, Wang P, Xiao Y, Zhong X, Wu R.
    Genet Test Mol Biomarkers; 2013 Nov 05; 17(11):807-13. PubMed ID: 23984644
    [Abstract] [Full Text] [Related]

  • 14. The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis.
    He S, Shi J, Mao J, Luo X, Liu W, Liu R, Yang F.
    Pathol Res Pract; 2019 Jun 05; 215(6):152375. PubMed ID: 30879885
    [Abstract] [Full Text] [Related]

  • 15. Identification of core miRNA based on small RNA-seq and RNA-seq for colorectal cancer by bioinformatics.
    Kou Y, Qiao L, Wang Q.
    Tumour Biol; 2015 Apr 05; 36(4):2249-55. PubMed ID: 25412953
    [Abstract] [Full Text] [Related]

  • 16. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW, Zhang W, Ma R.
    Oncol Rep; 2018 Mar 05; 39(3):1003-1010. PubMed ID: 29328395
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
    Gao C, Zhou C, Zhuang J, Liu L, Liu C, Li H, Liu G, Wei J, Sun C.
    J Cell Biochem; 2018 Aug 05; 119(8):7080-7090. PubMed ID: 29737570
    [Abstract] [Full Text] [Related]

  • 18. Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.
    Paziewska A, Mikula M, Dabrowska M, Kulecka M, Goryca K, Antoniewicz A, Dobruch J, Borowka A, Rutkowski P, Ostrowski J.
    Prostate; 2018 Feb 05; 78(3):178-185. PubMed ID: 29226351
    [Abstract] [Full Text] [Related]

  • 19. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA, Andahur EI, Valenzuela R, Castellón EA, Fullá JA, Ramos CG, Triviño JC.
    Oncotarget; 2016 Jan 26; 7(4):3993-4008. PubMed ID: 26675257
    [Abstract] [Full Text] [Related]

  • 20. MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.
    Aghaee-Bakhtiari SH, Arefian E, Naderi M, Noorbakhsh F, Nodouzi V, Asgari M, Fard-Esfahani P, Mahdian R, Soleimani M.
    Tumour Biol; 2015 Jun 26; 36(6):4203-12. PubMed ID: 25604141
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.